Arch Therapeutics, Inc. (ARTH)
Arch Therapeutics, Inc. is a development stage biotechnology company, which engages in the development and provision of hemostasis and sealant technology platform. Its product candidates include AC5 Devices, which designed to achieve hemostasis during surgical, wound, and interventional care. The company was founded by Rutledge Ellis-Behnke and Terrence W. Norchi on September 16, 2009 and is headquartered in Framingham, MA.
Address
235 WALNUT STREET, SUITE 6
FRAMINGHAM, MA 01702
Founded
2009
Number of Employees
8
Website
http://www.archtherapeutics.com
Insider Transactions
Filters
Keyboard Shortcuts: Show (a) | Close (Esc)